De Novo Biotherapeutics
PrivateLast Round
Series A
Nov 25, 2022
Total Funding Raised
$9.99M
Company Overview
De Novo Biotherapeutics is a biotechnology company that develops mRNA-encoded, NK cell-engaging bi- or multi-specific antibodies for the treatment of relapsed or refractory cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
De Novo Biotherapeutics Comparables
Compare De Novo Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 81% | |
| Therorna Inc. | 81% | |
| Eli Lilly and Company | 78% | |
De Novo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 25, 2022 | ||||
| Seed | Oct 21, 2021 |
De Novo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stonebridge Ventures | Series A |
| Heungkuk Securities | Series A |
| Atinum Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2022
Raised $6M from Heungkuk Securities, Atinum Investment, and Stonebridge Ventures.
- Oct 21, 2021
$4.24M round completed.
De Novo Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about De Novo Biotherapeutics's valuation, stock price, and market status.